Please select the option that best describes you:

How do you approach the timing of DMARD initiation in patients with active RA who are on treatment for latent TB?  

Is it different between DMARDs (csDMARDs, biologic DMARDs, and target synthetic DMARDs)?



Answer from: at Academic Institution
Sign in or Register to read more